E. Aguilera

发表

Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System

Debbie Gordon, C. Irace, C. D. De Block, 2019, Diabetes technology & therapeutics.

Where does capillary blood glucose stand following the IMPACT trial? Implications of a new way of measuring glucose in routine clinical practice.

Federico Vázquez, E. Aguilera, 2017, Endocrinologia, diabetes y nutricion.

Where does capillary blood glucose stand following the IMPACT trial? Implications of a new way of measuring glucose in routine clinical practice.

Federico Vázquez, E. Aguilera, 2017 .

Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population.

R. Casamitjana, R. Gomis, I. Conget, 2004, Diabetes care.

Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C

S. Ampurdanés, R. Casamitjana, I. Conget, 2001, Diabetic medicine : a journal of the British Diabetic Association.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus

D. Mauricio, Marta Hernández, A. Lecube, 2018, European Journal of Nutrition.

Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation

F. Ampudia-Blasco, A. Chico, C. Morales, 2020, Journal of diabetes science and technology.

Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.

N. Alonso, M. Pastor, I. Salinas, 2008, European journal of endocrinology.

Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population

D. Mauricio, M. Puig-Domingo, N. Alonso, 2015, Cardiovascular Diabetology.

Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial

F. Nicoletti, R. Casamitjana, R. Gomis, 2005, Diabetologia.

Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.

R. Casamitjana, R. Gomis, I. Conget, 2000, Diabetes care.

Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma

J. Reverter, A. Sanmartí, S. Holgado, 2010, Endocrine.

High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with Type 1 Diabetes Mellitus from a Mediterranean area

D. Mauricio, M. Puig-Domingo, N. Alonso, 2015, Acta Diabetologica.

Clinical characteristics, β‐cell function, HLA class II and mutations in MODY genes in non‐paediatric subjects with Type 1 diabetes without pancreatic autoantibodies

F. Nicoletti, R. Casamitjana, R. Gomis, 2005, Diabetic medicine : a journal of the British Diabetic Association.

HOMA test in diabetic patients with simultaneous pancreas and kidney transplantation.

R. Casamitjana, E. Esmatjes, L. Flores, 2002, Transplantation proceedings.

Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential

D. Maspoch, Federico Vázquez, S. Rodríguez-Fernández, 2019, Front. Immunol..

Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes

D. Tàssies, I. Salinas, J. Reverter, 2010, Thrombosis and Haemostasis.

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming

Federico Vázquez, I. Pujol-Autonell, S. Rodríguez-Fernández, 2020, Frontiers in Endocrinology.

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.

F. Nicoletti, R. Casamitjana, R. Gomis, 2003, Diabetes research and clinical practice.

E ffects of Nicotinamide and Intravenous Insulin Therapy in Newly Diagnosed Type 1 Diabetes

R. Casamitjana, R. Gomis, G. Sesmilo, 2022 .

Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

F. Ampudia-Blasco, Virginia Bellido, G. Díaz-Soto, 2022, Journal of diabetes science and technology.

Relationship between body mass index and age at diagnosis of Type 1 Diabetes in a Mediterranean area in the period of 1990-2004

Bn, C. Castell, I. Conget, 2007 .

Relationship between body mass index and age at diagnosis of Type 1 Diabetes in a Mediterranean area in the period of 1990-2004 Received for publication 20 December 2006 and accepted in revised form 23 February 2007.

C. Castell, I. Conget, M. Giménez, 2007 .

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

Ferran Briansó, D. Maspoch, Federico Vázquez, 2018, Front. Immunol..

Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes

D. Maspoch, Federico Vázquez, I. Pujol-Autonell, 2020, Scientific Reports.

Low prevalence of non‐alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease

D. Mauricio, M. Puig-Domingo, A. Lucas, 2017, Journal of diabetes.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Healthcare coverage for undocumented migrants in Spain: Regional differences after Royal Decree Law 16/2012.

B. Pérez-Gómez, Stefan Meyer, P. Gullón, 2016, Health policy.

Low Prevalence of Subclinical Atherosclerosis in Asymptomatic Patients With Type 1 Diabetes in a European Mediterranean Population

D. Mauricio, M. Puig-Domingo, N. Alonso, 2014, Diabetes Care.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Response to Decochez et al.: autoantibody levels during the early course of type 1 diabetes.

R. Casamitjana, I. Conget, E. Aguilera, 2000, Diabetes care.

[Usefulness of pulse oximetry in screening of carotid atherosclerosis in patients with type 2 diabetes mellitus].

J. Reverter, A. Sanmartí, E. Aguilera, 2010, Medicina clinica.